The Southeastern Cancer Study Group is a multi-modality, interdisciplinary, multi-institutional group organized to conduct trials of therapeutic regimens for the treatment of cancer. Studies are concerned with all stages and sites except for primary central nervous system and pediatric tumors. Emphasis has shifted from palliative therapy of late stage hematologic malignancies to protocols with curative intent for early stage, poor risk solid tumors. In order to upgrade the quality of relevance of work, additional efforts are proposed in quality control for medical, surgical and radiation oncology, pathology review, steroid receptors, and phase I studies. Five Community Clinical Oncology Programs will be associated with the SCSG, which will serve as a research base for each of these COOPs. The purpose of this association is to facilitate the CCOPs' integration into cooperative group multi-modality studies by providing the CCOPs data management of patients on SCSG studies, quality control of this data, and administrative guidance.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
5U10CA037421-03
Application #
3558081
Study Section
(SRC)
Project Start
1983-09-29
Project End
1986-08-31
Budget Start
1985-09-01
Budget End
1986-08-31
Support Year
3
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
Schools of Medicine
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294